Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Deep sequencing for HIV-1 clinical management.
2017 Update of the Drug Resistance Mutations in HIV-1.
Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.
Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
Next-generation sequencing and HIV drug resistance surveillance.